Skip to main content
. 2018 Nov 21;10:6039–6047. doi: 10.2147/CMAR.S181789

Table 3.

Overall survival analyses of the patients with extensive disease small cell lung cancer (n=186)

Univariate Multivariate
HR 95% CI P-value HR 95% CI P-value
Age, ≥75 vs <75 years 1.41 0.98–2.02 0.064
Sex, female vs male 1.19 0.77–1.82 0.44
Smoking status, former/current vs never 1.47 0.55–3.97 0.45
ECOG performance status, 2–4 vs 0–1 1.60 1.15–2.23 0.006 1.28 0.90–1.82 0.17
Brain metastasis, yes vs no 0.98 0.61–1.59 0.94
Albumin, low vs normal 1.84 1.32–2.55 <0.001 1.40 0.99–1.99 0.060
LDH, high vs normal 2.00 1.37–2.89 <0.001 1.73 1.18–2.54 0.005
Sodium, low vs normal 1.41 0.95–2.09 0.090
Platinum-based chemotherapy, yes vs no 0.73 0.53–1.01 0.058
M descriptors, M0/1a/1b vs M1c 2.21 1.58–3.09 <0.001 1.95 1.38–2.77 <0.001

Abbreviations: ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase.